K2LTS TELOMERASE INHIBITOR- telomerase inhibitor liquid 
K2LT LAB, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

84429-002

Active Ingredient

ginsenoside 23%

Purpose

Indications: This drug is indicated for cancer patients, people with a family history of cancer, or people exposed to work with radioactivity.

Use

Product Benefits: This product can inhibit the activity of telomerase, thus preventing the proliferation and growth of tumor cells;

Warnings

This product should not be used in combination with antibiotics;

Do not use

This product should not be used in patients who are allergic to any component of this product;

When Using

Precautions: Combined use with other drugs or increased exposure to this product may result in clinically significant adverse reactions. Combined use with other drugs may significantly decrease the concentration of this product, leading to decreased therapeutic effect of the drug combination.

Stop Use

If there is any discomfort during use, please discontinue this product.

Ask Doctor

If the patient has any underlying medical condition, please consult the doctor before taking this product.

Keep Oot Of Reach Of Children

Please keep this product away from children. If the child accidentally ingests this product, please seek medical help immediately.

Directions

Usage: Twist off the bottle cap and take it directly; Take it twice a day; Do not overdose.

Other information

Storage: This product should be stored in a cool, dry, dark place with the temperature of 16℃-27℃ and the humidity ≤ 50%.

Inactive ingredients

EGCG Sulforaphane cordycepin Ergothioneine Selenium Sodium benzoate

PRINCIPAL DISPLAY PANEL

1

K2LTS TELOMERASE INHIBITOR 
telomerase inhibitor liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:84429-002
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GINSENOSIDES (UNII: 3K198YD54P) (GINSENOSIDES - UNII:3K198YD54P) GINSENOSIDES23 g  in 100 
Inactive Ingredients
Ingredient NameStrength
SELENIUM (UNII: H6241UJ22B)  
CORDYCEPIN (UNII: GZ8VF4M2J8)  
SULFORAPHANE (UNII: GA49J4310U)  
ERGOTHIONEINE (UNII: BDZ3DQM98W)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
EPIGALLOCATECHIN GALLATE (UNII: BQM438CTEL)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:84429-002-0120 in 1 BOX; Type 0: Not a Combination Product06/20/2024
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other06/20/2024
Labeler - K2LT LAB, LLC (072189878)
Establishment
NameAddressID/FEIBusiness Operations
K2LT LAB, LLC072189878manufacture(84429-002)

Revised: 6/2024
Document Id: 1b4daf1d-a7a6-8fd1-e063-6294a90a817e
Set id: 1b4daf1d-a7a5-8fd1-e063-6294a90a817e
Version: 1
Effective Time: 20240620
 
K2LT LAB, LLC